CONAGRA BRANDS INC. (CAG) Q2 2025 Earnings Summary
Executive Summary
- Q2 FY25 was a mixed quarter: organic net sales returned to growth (+0.3%) with volumes +0.4%, but adjusted operating margin compressed to 15.3% (-57 bps YoY) as higher input inflation and FX offset productivity; adjusted EPS was $0.70 (-1.4% YoY) while reported EPS was $0.59 (-1.7% YoY) .
- Management cut FY25 outlook: adj. operating margin to ~14.8% (from 15.6–15.8%), adj. EPS to $2.45–$2.50 (from $2.60–$2.65), and raised FCF conversion to >100%; drivers are higher-than-expected inflation (esp. protein; cocoa/sugar also) and FX headwinds .
- Category execution improved: Grocery & Snacks net sales +2.0% with adj. OI +4.8%, Refrigerated & Frozen volumes +1.9% but price/mix -1.9% (adj. OI -10.8%); International pressured by M&A/FX; Foodservice down modestly with traffic softness .
- Call color: no “Thanksgiving timing” effect; trade investment underspend in Q2 redeployed to Q3; Q3 operating margin expected to trough with Q4 recovery; pricing selective (offsetting cocoa/sugar) while preserving volume momentum amid deferred protein cost relief .
- Street estimates: S&P Global consensus was unavailable at time of analysis due to access limits; versus prior company guidance, the quarter’s narrative and guide cut likely reset expectations lower (see Guidance Changes) .
What Went Well and What Went Wrong
-
What Went Well
- Volume-led return to growth: organic volume +0.4% and organic sales +0.3%; total gross margin held flat YoY at 26.5% despite inflation (adj. GM 26.4%) .
- Grocery & Snacks outperformed: net sales +2.0% with price/mix +0.9% and volume +0.3%; adj. OI +4.8% to $296M; share gains in popcorn, dinners/entrees, chili, seeds .
- Strong free cash flow discipline: H1 FY25 FCF $538.8M; net debt reduced to $8.43B; TTM leverage 3.54x .
- Management quote: “Our business returned to growth in the second quarter… our investments paid off, driving strong market share performance” .
-
What Went Wrong
- Margin pressure from cost inflation/FX: adj. operating margin fell to 15.3% (-57 bps YoY); adj. gross profit -2.3% YoY (to $842M) .
- Refrigerated & Frozen profit decline: flat sales on -1.9% price/mix and +1.9% volume; adj. OI -10.8% as COGS inflation and operating leverage weighed .
- International headwinds: net sales -12.9% (M&A -8.4%, FX -3.8%); adj. OI -2.9% .
- Analyst concerns: increased H2 inflation (~4%) and deferred protein cost relief forced guide down; limited new pricing to protect volume momentum .
Financial Results
Segment Net Sales ($B)
Adjusted Operating Profit ($M)
Q2 FY25 KPI Decomposition (% YoY, Organic)
Cash Flow and Leverage (YTD through Q2)
Guidance Changes
Why the change: management cited higher-than-expected inflation (notably protein; also cocoa/sugar) and unfavorable FX in H2; selective pricing to offset cocoa/sugar while preserving top-line momentum; protein cost relief deferred .
Earnings Call Themes & Trends
Management Commentary
- “Our business returned to growth in the second quarter despite a continued challenging consumer environment as our investments paid off, driving strong market share performance.” — Sean Connolly, CEO .
- “There really was not a Thanksgiving timing effect for our company... our inventory levels with customers were essentially even with the year ago.” — Sean Connolly .
- “The EPS call down today equates basically identically to the inflation in the back half versus what we had previously expected, that's the majority of it, plus FX.” — Sean Connolly .
- “We do believe operating margin will be the lowest of all the quarters for the year [in Q3]... inflation will be higher in Q3 than Q4.” — Dave Marberger, CFO .
Q&A Highlights
- Trade spend and timing: Q2 trade came in below plan and was redeployed to Q3; management reiterated that investments have been in place five quarters and are working to drive volumes/share .
- Inflation and pricing posture: Incremental H2 inflation (protein primary; cocoa/sugar also) plus FX drove the guide cut; limited new pricing to protect momentum, with targeted pricing for cocoa/sugar .
- Margin cadence: Q3 operating margin expected to be the lowest of the year with recovery in Q4; additional slotting/innovation and higher inflation load in Q3 cited .
- Consumption vs shipments: No Thanksgiving timing benefit; shipments +1% vs consumption +0.6%; channel inventory even YoY .
- Category/strategy: Confidence in frozen leadership amid competitor capacity adds; GLP-1-friendly “On Track” messaging on Healthy Choice to capture health trends .
Estimates Context
- S&P Global consensus EPS/revenue estimates were unavailable at the time of analysis due to access limitations; therefore, we cannot present vs-consensus comparisons for Q2 FY25 or FY25. We note company guidance was reduced (adj. EPS $2.45–$2.50; adj. operating margin ~14.8%), which likely implies lower Street trajectory near term absent a cost/inflation reversal .
Key Takeaways for Investors
- Volume momentum returned with organic growth and broad share gains, especially in frozen and snacks; management is prioritizing sustained investment to protect this momentum .
- Guidance reset reflects higher H2 inflation (~4%) and FX; watch protein cost curves and FX as key sensitivities into Q3/Q4 .
- Margin trough anticipated in Q3 with recovery in Q4 as investment timing and inflation cadence normalize; any upside requires faster cost relief and/or improved operating leverage .
- Refrigerated & Frozen profitability is the swing factor: volumes improved but price/mix and cost inflation pressured margins; execution on productivity and mix will be crucial .
- Strong cash discipline underpins >100% FY25 FCF conversion and continued deleveraging; leverage expected ~3.4x in FY25 with a path to ~3.0x by FY26 per management .
- Selective pricing (cocoa/sugar) suggests limited margin recapture near term; the strategy aims to defend volumes/share vs. value-seeking consumers and a rational promotional backdrop .
- Tactical watch items for trading: Q3 margin trough vs expectations, protein cost trajectory, frozen category consumption trends, and the magnitude of any Q4 recovery in operating margin .